Ion News and Research

RSS

Fraunhofer Presents Exciting Battery Innovations for the Medical Sector

At MEDICA 2022, NewsMedical spoke with Andreas Wuersig from Fraunhofer ISIT about the current and potential applications of their battery research and technology in the medical sector.

From MEDICA 15 Dec 2022

New method uses light to change long-term behavior of neurons

Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and MIT have developed a new method to target diseased neurons in the brain and change their long-term behavior using light, paving the way for potential new treatments for neurological conditions such as epilepsy and autism.

8 Dec 2022

UKSRC researchers work with community partners to protect Kentuckians from 'forever chemicals'

Nearly every person in the United States has been exposed to per- and polyfluorinated alky substances (PFAS) at some point in their life.

7 Dec 2022

Metrion Biosciences and The KCNC1 Foundation Collaborate on New Ion Channel Modulators

...

From Metrion Biosciences Limited 7 Dec 2022

Study shows how ketamine administration starkly changes neuronal activity patterns in the brain

Ketamine, an established anesthetic and increasingly popular antidepressant, dramatically reorganizes activity in the brain, as if a switch had been flipped on its active circuits, according to a new study by Penn Medicine researchers.

1 Dec 2022

Metrion Biosciences invests in new High Throughput Screening capability and expanded facilities

Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service.

From Metrion Biosciences Limited 1 Dec 2022

Specific genetic variant linked to early-onset childhood epilepsy discovered

Researchers at Children's Hospital of Philadelphia (CHOP) have discovered a specific genetic variant in SCN1A, the most common genetic epilepsy, that leads to an earlier onset of epilepsy, with clinical features distinct from other epilepsies.

30 Nov 2022

Bioorthogonal system for targeted release of nitrite ions into cancer cells

A team of researchers writing in the journal Angewandte Chemie has developed a bioorthogonal molecular system for the targeted introduction of nitrite ions into cells.

30 Nov 2022

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd. (ASX:EX1), a company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), today announced they had entered into a formal collaboration.

From Sartorius 23 Nov 2022

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

Researchers assessed the effectiveness of SARS-CoV and SARS-CoV-2 envelope proteins against HIV-1.

22 Nov 2022

Are fungal mycelium skin-derived MycelioTronics an environmentally friendly substitute for electronics?

Researchers proposed a novel approach to develop flexible and biodegradable electronics called MycelioTronics, which could substitute for electronic substrate material.

15 Nov 2022

Copper and copper-binding proteins could be potential targets for cancer treatment

For cancer cells to grow and spread around the human body, they need proteins that bind copper ions. New research about how cancer-related proteins bind the metal and how they interact with other proteins, opens up potential new drug targets in the fight against cancer.

10 Nov 2022

Ion News and Research

Fraunhofer Presents Exciting Battery Innovations for the Medical Sector

New method uses light to change long-term behavior of neurons

UKSRC researchers work with community partners to protect Kentuckians from 'forever chemicals'

Metrion Biosciences and The KCNC1 Foundation Collaborate on New Ion Channel Modulators

Study shows how ketamine administration starkly changes neuronal activity patterns in the brain

Metrion Biosciences invests in new High Throughput Screening capability and expanded facilities

Specific genetic variant linked to early-onset childhood epilepsy discovered

Bioorthogonal system for targeted release of nitrite ions into cancer cells

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

Are fungal mycelium skin-derived MycelioTronics an environmentally friendly substitute for electronics?

Copper and copper-binding proteins could be potential targets for cancer treatment

Study uncovers a previously unknown propofol effect in neurons

Higher viscosity of extracellular fluid enhances cancer dissemination

New research lays the foundation for more effectively treating pediatric brain tumor

Researchers fabricate cerebral cortical tissues in 3D and functionally integrate them into a brain lesion in mice

New system to detect cancer-related markers on CTCs

What is the impact of SARS-CoV-2 on HIV-1 infectivity?

RIT professor receives grant to investigate new therapeutic approaches for scleroderma

Study reveals TBX20 as a vital regulator of direct human cardiac reprogramming

Enhancing confidence in chemical ionization spectrometry data eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News